Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study

Einat Shacham-Shmueli; Amit Itay; Ofer Margalit; Raanan Berger; Sharon Halperin; Menucha Jurkowicz; Einav G. Levin; Itzchak Levy; Liraz Olmer; Gili Regev-Yochay; Yaniv Lustig; Galia Rahav

doi:10.1016/j.ejca.2021.10.019

Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study

Einat Shacham-Shmueli, Amit Itay, Ofer Margalit, Raanan Berger, Sharon Halperin, Menucha Jurkowicz, Einav G. Levin, Itzchak Levy, Liraz Olmer, Gili Regev-Yochay, Yaniv Lustig, Galia Rahav

Tel Aviv University

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	285-286
Number of pages	2
Journal	European Journal of Cancer
Volume	160
DOIs	https://doi.org/10.1016/j.ejca.2021.10.019
State	Published - Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1016/j.ejca.2021.10.019

Cite this

Shacham-Shmueli, E., Itay, A., Margalit, O., Berger, R., Halperin, S., Jurkowicz, M., Levin, E. G., Levy, I., Olmer, L., Regev-Yochay, G., Lustig, Y., & Rahav, G. (2022). Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study. European Journal of Cancer, 160, 285-286. https://doi.org/10.1016/j.ejca.2021.10.019

@article{64f552e16bc240aa9eadc63413af6afd,

title = "Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study",

author = "Einat Shacham-Shmueli and Amit Itay and Ofer Margalit and Raanan Berger and Sharon Halperin and Menucha Jurkowicz and Levin, \{Einav G.\} and Itzchak Levy and Liraz Olmer and Gili Regev-Yochay and Yaniv Lustig and Galia Rahav",

year = "2022",

month = jan,

doi = "10.1016/j.ejca.2021.10.019",

language = "الإنجليزيّة",

volume = "160",

pages = "285--286",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon Press",

}

Shacham-Shmueli, E, Itay, A, Margalit, O, Berger, R, Halperin, S, Jurkowicz, M, Levin, EG, Levy, I, Olmer, L, Regev-Yochay, G, Lustig, Y & Rahav, G 2022, 'Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study', European Journal of Cancer, vol. 160, pp. 285-286. https://doi.org/10.1016/j.ejca.2021.10.019

TY - JOUR

T1 - Letter of response to comment on

T2 - Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study

AU - Shacham-Shmueli, Einat

AU - Itay, Amit

AU - Margalit, Ofer

AU - Berger, Raanan

AU - Halperin, Sharon

AU - Jurkowicz, Menucha

AU - Levin, Einav G.

AU - Levy, Itzchak

AU - Olmer, Liraz

AU - Regev-Yochay, Gili

AU - Lustig, Yaniv

AU - Rahav, Galia

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85121204139&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2021.10.019

DO - 10.1016/j.ejca.2021.10.019

M3 - رسالة

C2 - 34840027

SN - 0959-8049

VL - 160

SP - 285

EP - 286

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this